降低MPC1的调节通过STAT3通路促进HCC细胞的增殖和转移
Dandan Shan1,2, Qiuxian Zheng2, Zhi Chen3
1Department of Infectious Diseases, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
线粒体酸盐载体1 (MPC1) 在肝细胞癌 (HCC) 中降低,促进瘤生长. 恢复MPC1可能通过影响癌细胞代谢和瘤微环境,为HCC提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症新陈代谢 癌症新陈代谢
背景情况:
- 肝细胞癌 (HCC) 是一个全球性的健康问题,需要新的治疗点.
- 线粒体酸盐载体1 (MPC1) 表达在各种癌症中发生变化,但其在HCC中的作用尚不清楚.
研究的目的:
- 研究MPC1在HCC发育和进展中的作用.
- 探索MPC1作为HCC治疗点的潜力.
主要方法:
- 在HCC患者数据中分析MPC1表达 (GEO数据集,Kaplan-Meier绘图器).
- 在MPC1-调节的HCC细胞系中进行功能性测试 (CCK8,殖民地形成,测试,流细胞计).
- 线粒体和细胞代谢的评估.
主要成果:
- 在HCC组织中减少MPC1表达与预后不佳和不良的临床病理特征相关.
- 低MPC1表达增强HCC细胞恶性瘤,并改变线粒体能量代谢.
- 在HCC中MPC1的瘤抑制作用可能涉及与STAT3.3的相互作用.
结论:
- 在HCC中,MPC1充当瘤抑制剂,其减少表达促进恶性表型.
- MPC1影响HCC细胞的线粒体代谢和瘤微环境.
- 针对MPC1,可能通过其与STAT3的相互作用,为HCC提供了一个新的治疗途径.
更多相关视频
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
The JAK-STAT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Induced Pluripotent Stem Cells
Somatic...
